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REPORTES DE CASO
Ischemic stroke in a young patient due to protein S deficiency in 
the context of muscular dystrophy - case report
Accidente cerebrovascular isquémico por déficit de proteína S 
en el contexto de distrofia muscular
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ABSTRAC
A 19-year-old woman with a 6-year history, consisting of frequent falls and weakness due to loss of 
strength in the lower extremities. During the last 10 hours, she presented a sudden episode of left 
hemiplegia, deviation of the labial commissure to the right, dysarthria and four emetic episodes. She 
was diagnosed with an ischemic stroke caused by a deficiency of the S-protein and, in addition, a 
muscular dystrophy. This case report may indicate a relationship between muscular dystrophy and 
ischemic stroke caused by a protein S deficiency.
Key words: stroke; thrombophilia; muscular dystrophies.
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RESUMEN
Mujer de 19 años con historia de 6 años de evolución consistente en caídas frecuentes y debilidad 
debido a la pérdida de fuerza en los miembros inferiores. Durante las últimas 10 horas, presentó un 
episodio repentino de hemiplejia izquierda, desviación de la comisura labial a la derecha, disartria y 
cuatro episodios eméticos. Ella fue diagnosticada con accidente cerebrovascular isquémico causado 
por una deficiencia de la proteína S y además con distrofia muscular. Este reporte de caso puede 
indicar una relación entre la distrofia muscular y el accidente cerebrovascular isquémico causado por 
una deficiencia de proteína S.
Palabras clave: Accidente cerebrovascular; trombofilia; distrofia muscular.
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RESUMO
Mulher de 19 anos com história de 6 anos, consistindo de quedas frequentes e fraqueza devido à 
perda de força nas extremidades inferiores. Durante as últimas 10 horas, apresentou episódio súbito 
de hemiplegia esquerda, desvio da comissura labial à direita, disartria e quatro episódios eméticos. 
Ela foi diagnosticada com um acidente vascular cerebral isquêmico causado por uma deficiência da 
proteína S e, além disso, uma distrofia muscular. Este relato de caso pode indicar uma relação entre 
distrofia muscular e acidente vascular cerebral isquêmico causado por deficiência de proteína S.
Palavras-chave: acidente vascular cerebral; trombofilia; distrofias musculares.
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BACKGROUND
Strokes are the second leading cause of mortali-
ty worldwide, originating 5.5 million deaths per 
year and in addition, they are the main cause of 
disability (1, 2). Ischemic stroke in young people is 
related to rare risk factors; such as cardiac embo-
lism (2-3%), aortic dissection (10-25%), foramen 
ovale (24-50%), antiphospholipid syndrome 
(10%), factor V Leiden (3-7,5%), antithrombin III 
deficiency (5-8%), protein C deficiency (4-11%), 
protein S deficiency (6-23%), migraine (20-24%), 
pregnancy (7,5%), puerperium (7,5%), use of oral 
contraceptives (10-40%) and illicit drugs (9-20%) 
(3, 4). Only 2% of patients affected by a stroke 
have an early age (5) and its annual incidence 
is 2.4 per 100,000 people (6). In the literature, 
some cases of stroke have been described due 
to protein S deficiency in young patients (7) and 
this state of hypercoagulability occurs in one in 
20,000 people (8). Muscular dystrophy has an 
incidence, in its most frequent form of 15.9 to 
19.5 per 100,000 births (10), 6 cases of stroke 
have been reported in patients with muscular 
dystrophy and these were caused by embolism of 
cardiac origin (11).  A case describing the presen-
tation of stroke, S-protein deficiency and mus-
cular dystrophy was not found in the literature 
search. The objective of this article is to describe 
the clinical case of a 19-year-old woman with a 
history of migraine and hypothyroidism who was 
admitted to an emergency department due to 
neurological deterioration and who is diagnosed 
with a stroke, protein S deficiency and muscular 
dystrophy.
CLINICAL CASE
Anamnesis and physical examination:
A 19-year-old woman with a 6-year history, con-
sisting of frequent falls and weakness due to loss 
of strength in the lower extremities. During the 
last 10 hours, she presented a sudden episode 
of left hemiplegia, deviation of the labial com-
missure to the right, dysarthria and four emetic 
episodes. 1 year ago, she had presented a similar 
episode that evolved spontaneously. 
During the physical examination her blood pres-
sure was 130/85 mm Hg, heart rate of 50 beats 
per minute, respiratory rate 22 per minute and 
temperature of 36.5 °C. In the neurological exa-
mination, she was sleepy, aware of person, time 
and place, with mechanical dysarthria, without 
alterations in the content or course of thought. 
At the examination of the cranial nerves, the only 
positive finding was a deviation of the labial com-
missure to the right. When assessing the motor 
system muscle strength, it was evident 1/5 in the 
left hemi body and 3/5 in the right hemi body 
of the body predominantly proximal, hypotonia 
in the four extremities, generalized muscle ten-
dinous reflexes + / ++++, left Babinsky, no me-
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ningeal signs, no abnormal movements, the rest 
of the physical examination without alterations. 
Probable neurovascular syndrome and proximal 
weakness syndrome are diagnosed in the young 
patient under study.
DIAGNOSTIC AIDS
DIAGNOSTIC IMAGING
Cranial Computed Tomography (CT):
Lesion located towards the white matter depth, 
near the head of the caudate nucleus of approxi-
mately 23 x 17 x 18 mm, that does not produce 
mass effect. The image found in the nuclei of the 
left base is the Virchow Robin space and the other 
image in the nuclei of the base of the right side 
corresponds to a hypodense image of sub-acute 
characteristics that compromises the right inter-
nal capsule, wedge-shaped (See image 1).
Image 1. Cranial Computed Tomography (CT).
Lesion located towards the white matter depth, near the head 
of the caudate nucleus of approximately 23 x 17 x 18 mm, 
that does not produce mass effect. 
Simple And Contrasted Brain Magnetic 
Resonance Imaging (MRI):
Simple and contrasted brain magnetic resonance 
imaging where a right extensive basal nucleus in-
farction without hemorrhagic transformation was 
observed with cystic malacia zone in the territory 
of lenticulostriate arteries of the lateral group in 
the left basal nucleated region (image 2).
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Image 2. Simple Brain Magnetic Resonance Imaging
Simple brain magnetic resonance imaging where a right ex-
tensive basal nucleus infarction without hemorrhagic trans-
formation was observed with cystic malacia zone in the terri-
tory of lenticulostriate arteries of the lateral group in the left 
basal nucleated region.
Brain Panangiography
Image in which an occlusion of the right middle 
cerebral arterial was identified in its M1 segment, 
with retrograde perfusion through the pial anas-
tomoses (Image 3).
Image 3. Brain panangiography
Image in which an occlusion of the right middle cerebral arte-
rial was identified in its M1 segment, with retrograde perfu-
sion through the pial anastomoses.
Additionally, other diagnostic images were reques-
ted, such as the angioresonance of the vessels of 
the neck that were normal, the transthoracic echo-
cardiogram that showed strong dilation of right ca-
vities with severe triscuspidea insufficiency without 
cardiac malformations, short circuits or vegetations.
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Laboratory test:
In the study of the etiology of ischemic cerebro-
vascular accident, infectious causes (syphilis, HIV 
and endocarditis), autoimmune (SLE, vasculitis), 
cardiac (short circuits, arrhythmias), carotid vas-
cular origin were ruled out and within the hyper-
coagulable state the protein S deficit was con-
firmed, in table 1 all the requested laboratories, 
their results and reference values  are reported.
Table 1. Labs requested in Ischemic stroke in a young patient. 
Laboratory Reference value Result Interpretation
Circulating anticoagulant lupus -- 40,4 seconds Negative for lupus anticoagulant
Protein C Coagulation 70 to 140 % 80% Negative for protein C deficit
Protein S coagulation 63  to 149 % 19,5% Positive for protein S deficiency
Total CK Creatin Kinase 38 to 234 IU/L 133 IU/L Negative for rhabdomylosis
Glycoprotein Beta 2 IgM 0 to 20 6,15
Negative for antiphospholipid 
antibody syndrome
ANAS, ENAS and Anti DNA -- --
Negatives for autoimmune 
pathology (SLE, etc)
Blood picture, Glycemia, Creati-
nine, urine and electrolytes test
-- --
Hemogram, basic chemistry and 
normal renal function
HLA genetic study with 
NGS-Illumina method 
---- Negative
The result does not confirm 
Fabry’s disease
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A muscle weakness study was performed through 
a electromyography and nerve conduction studies 
of all four limbs, which reported pattern of proxi-
mal myopathy in lower limbs. Muscle biopsy 
reported: skeletal muscle with strong variation 
in size of the fibers with the presence of some 
hyaline fibers that increased in size and others 
of atrophic appearance, together with myopathy 
changes with degeneration and myofibral rege-
neration. There is endomysial fibrosis and infiltra-
tes by adipose tissue, the morphology described 
is compatible with muscular dystrophy.
Treatment:
The patient was treated by a team of specialists, 
and received support from the services of inter-
nal medicine, neurology, nutrition, psychiatry and 
physiotherapy. The anticoagulation was initiated 
with Enoxaparin 1 mg per kg twice a day and 
warfarin 2.5 mg orally once a day, upon reaching 
the therapeutic levels of INR (between 2 and 3) 
the low molecular weight heparin was suspen-
ded. She was discharged 2 weeks later and con-
tinued the controls every 3 months with internal 
medicine and neurology.
Follow-up:
After more than 1 year of treatment, she presents 
left hemiplegia, moves in a wheelchair, regained 
speech. Within the renal function, a persistent 
proteinuria was developed in nephrotic range, 
ascites with hypertensive gradient portal, she is 
in treatment with warfarin 2.5 mg orally once a 
day, furosemide 40 mg orally once a day and phy-
sical therapy.
DISCUSSION
The cerebrovascular stroke in a young patient 
can be defined as the one that is presented up 
to the age of 55 years and one of its biggest cha-
llenges is to establish the triggering cause, being 
cardioembolic origin and arterial dissection the 
most frequent. In addition, when these etiologies 
are ruled out, other more rare entities should be 
searched for through angiography, cerebrospinal 
fluid study, vasculitis and thrombophilia tests , 
and genetic studies among others (12). 
Half of hereditary thrombophilias are due to a 
mutation of factor V Leiden and the mutation of 
the prothrombin gene, the rest of the cases are ex-
plained by alterations of antithrombin III, protein 
C and S (13). The alterations in the protein S can 
be quantitative or qualitative and their presence 
means an increased risk of thrombotic events. 
They are classified into three groups: type I, when 
there are low levels of total protein S, free protein 
S and protein activity S; type II when there are 
normal levels of total protein S and free protein 
S with low levels of protein S activity; and, type 
III, when there are low levels of free protein S and 
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activity of protein S with normal levels of total 
protein S (14). 
Muscular dystrophy is characterized  muscle 
weakness that usually affects certain groups de-
pending on the type, leading in time to a greater 
or lesser degree of disability and among its 
diagnostic methods we have electromyography, 
genetic studies and muscle biopsy (15). 
In the present case, it was observed the onset 
of symptoms in adolescence with loss of stren-
gth in the proximal muscle groups, findings that 
were confirmed with the electromyography and 
biopsy. Additionally during the course of her 
myopathy, she presented symptoms and signs of 
a cerebrovascular stroke. In the study of its etio-
logy, the protein S deficiency was confirmed, due 
to the rare coexistence of these three diseases. 
The disclosure of this case is important with the 
aim of contributing to the development of new 
knowledge and although the case reports do not 
allow to establish causality, it is possible to ge-
nerate some questions such as: Are myopathies 
a risk factor for the development of hypercoa-
gulability events and/or thrombosis? Thrombotic 
events in patients with muscular dystrophy have 
been caused by cardiomyopathy; nevertheless, 
in this case report, protein S deficiency was des-
cribed as the main cause of stroke. In the review 
of the literature we found a study that described 
an alteration in the coagulation markers in 96% 
of the patients with muscular dystrophy, this may 
suggest that in addition to the cardiomyopathy 
and the loss of mobility, the alterations in the 
markers of coagulation are frequent in patients 
with muscular dystrophy and also a risk factor for 
thrombotic events. This question may be answe-
red in the future with other higher category re-
search designs such as a case-control study.
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